About Tourmaline Bio
Tourmaline Bio is a company based in New York (United States) founded in 2021 was acquired by Novartis in September 2025. It operates as a HealthTech. Tourmaline Bio offers products and services including Transformative Medicines. Tourmaline Bio operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tourmaline Bio, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tourmaline Bio
Tourmaline Bio offers a comprehensive portfolio of products and services, including Transformative Medicines.
Medicines are developed for inflammatory and immune diseases.
People of Tourmaline Bio
Unlock access to complete
Funding Insights of Tourmaline Bio
Detailed funding history for Tourmaline Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Tourmaline Bio
Tourmaline Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Locked | Locked | Locked |
Investor details for Tourmaline Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tourmaline Bio
Investment portfolio details for Tourmaline Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tourmaline Bio
Detailed financials for Tourmaline Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tourmaline Bio Comparisons
Peer comparison for Tourmaline Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tourmaline Bio
Tourmaline Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
Detailed competitors of Tourmaline Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tourmaline Bio
Complete news archive for Tourmaline Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tourmaline Bio
Tourmaline Bio was founded in 2021.
Tourmaline Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Tourmaline Bio is focused on the development of transformative medicines aimed at establishing new standards of care for patients with life-altering inflammatory and immune diseases. The company operates in the healthcare sector, specifically targeting areas with high unmet medical needs. Solutions are crafted by a dedicated team of entrepreneurs, physicians, and industry experts committed to advancing patient care through innovative pharmaceutical approaches.
Tourmaline Bio's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
Tourmaline Bio offers Transformative Medicines.
Tourmaline Bio has 1 investor. Key investors include Novartis.